Supernus Pharmaceuticals | SUPN - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 11.22B 655M 2026-03
ANI Pharmaceuticals USD 274.47M 19.04M 2026-06
Aurora Cannabis CAD 44.58M 3.68M 2026-03
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Canopy Growth CAD 36.29M 104.13M 2026-03
Cara Therapeutics USD 2.24M 2.26M 2025-03
Corcept Therapeutics USD 76.92M 37.85M 2026-06
Eisai JPY 253.13B 26.12B 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Novo Nordisk DKK 114.94B 8.68B 2026-06
Pacira USD 132.42M 6.78M 2026-06
Perrigo USD 697.1M 84.3M 2026-03
Pfizer USD 16.19B 19M 2026-06
Supernus Pharmaceuticals USD 211.66M 29.47M 2026-06
United Therapeutics USD 310.3M 1.7M 2026-06
Xeris Pharmaceuticals USD 56.29M 5.24M 2026-03